The issue of the correct use of probiotics in the absence of recommendations

[1] Adams M.R., Marteau P.: On the safety of lactic acid bacteria from food. Int. J. Food Microbiol., 1995; 27: 263–264 AdamsM.R. MarteauP. On the safety of lactic acid bacteria from food Int. J. Food Microbiol. 1995 27 263 264 10.1016/0168-1605(95)00067-T Search in Google Scholar

[2] Azad A.K., Sarker M., Li T., Yin J.: Probiotic species in the modulation of gut microbiota: An overview. Biomed. Res. Int., 2018; 2018: 9478630 AzadA.K. SarkerM. LiT. YinJ. Probiotic species in the modulation of gut microbiota: An overview Biomed. Res. Int. 2018 2018 9478630 10.1155/2018/9478630 Search in Google Scholar

[3] Bartnicka A., Szachta P., Gałęcka M.: Faecal microbiota transplant – prospects and safety. Pomeranian J. Life Sci., 2015; 61: 282–286 BartnickaA. SzachtaP. GałęckaM. Faecal microbiota transplant – prospects and safety Pomeranian J. Life Sci. 2015 61 282 286 10.21164/pomjlifesci.98 Search in Google Scholar

[4] Besselink M.G., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M., Nieuwenhuijs V.B., Bollen T.L., van Ramshorst B., Witteman B.J., Rosman C., Ploeg R.J., Brink M.A., Schaapherder A.F., Dejong C.H., et al.: Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet, 2008; 371: 651–659 BesselinkM.G. van SantvoortH.C. BuskensE. BoermeesterM.A. van GoorH. TimmermanH.M. NieuwenhuijsV.B. BollenT.L. van RamshorstB. WittemanB.J. RosmanC. PloegR.J. BrinkM.A. SchaapherderA.F. DejongC.H. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial Lancet 2008 371 651 659 10.1016/S0140-6736(08)60207-X Search in Google Scholar

[5] Binek M.: Mikrobiom człowieka – zdrowie i choroba. Post. Mikrobiol., 2012; 51: 27–36 BinekM. Mikrobiom człowieka – zdrowie i choroba Post. Mikrobiol. 2012 51 27 36 Search in Google Scholar

[6] Bischoff S.C., Escher J., Hébuterne X., Kłęk S., Krznaric Z., Schneider S., Shamir R., Stardelova K., Wierdsma N., Wiskin A.E., Forbes A.: ESPEN practical guideline: Clinical nutrition in inflammatory bowel disease. Clin. Nutrition, 2020; 39: 632–653 BischoffS.C. EscherJ. HébuterneX. KłękS. KrznaricZ. SchneiderS. ShamirR. StardelovaK. WierdsmaN. WiskinA.E. ForbesA. ESPEN practical guideline: Clinical nutrition in inflammatory bowel disease Clin. Nutrition 2020 39 632 653 10.1016/j.clnu.2019.11.00232029281 Search in Google Scholar

[7] Brown W.R.: Fecal microbiota transplantation in treating Clostridium difficile infection. J. Dig. Dis., 2014; 15: 405–408 BrownW.R. Fecal microbiota transplantation in treating Clostridium difficile infection J. Dig. Dis. 2014 15 405 408 10.1111/1751-2980.1216024825534 Search in Google Scholar

[8] Charteris W.P., Kelly P.M., Morelli L., Collins J.K.: Antibiotic susceptibility of potentially probiotic Lactobacillus species. J. Food Prot., 1998; 61: 1636–1643 CharterisW.P. KellyP.M. MorelliL. CollinsJ.K. Antibiotic susceptibility of potentially probiotic Lactobacillus species J. Food Prot. 1998 61 1636 1643 10.4315/0362-028X-61.12.1636 Search in Google Scholar

[9] Cichy W., Gałęcka M., Szachta P.: Probiotyki jako alternatywne rozwiązanie i wsparcie terapii tradycyjnych. Zakażenia, 2010; 6: 2–8 CichyW. GałęckaM. SzachtaP. Probiotyki jako alternatywne rozwiązanie i wsparcie terapii tradycyjnych Zakażenia 2010 6 2 8 Search in Google Scholar

[10] Cremon C., Barbaro M.R., Ventura M., Barbara G.: Pre- and probiotic overview. Curr. Opin. Pharmacol., 2018; 43: 87–92 CremonC. BarbaroM.R. VenturaM. BarbaraG. Pre- and probiotic overview Curr. Opin. Pharmacol. 2018 43 87 92 10.1016/j.coph.2018.08.01030219638 Search in Google Scholar

[11] Curragh H.J., Collins M.A.: High levels of spontaneous drug resistance in Lactobacillus. J. Appl. Bacteriol., 1992; 73: 31–36 CurraghH.J. CollinsM.A. High levels of spontaneous drug resistance in Lactobacillus J. Appl. Bacteriol. 1992 73 31 36 10.1111/j.1365-2672.1992.tb04965.x Search in Google Scholar

[12] Dopuszczanie do obrotu suplementów diety. Najwyższa Izba Kontroli. https//www.nik.gov.pl/plik/id.13031,vp,15443.pdf. (18.12.2019) Dopuszczanie do obrotu suplementów diety Najwyższa Izba Kontroli https//www.nik.gov.pl/plik/id.13031,vp,15443.pdf. (18.12.2019) Search in Google Scholar

[13] Doron S., Snydman D.R.: Risk and safety of probiotics. Clin. Infect. Dis., 2015; 60, Suppl. 2: 129–134 DoronS. SnydmanD.R. Risk and safety of probiotics Clin. Infect. Dis. 2015 60 Suppl. 2 129 134 10.1093/cid/civ085449023025922398 Search in Google Scholar

[14] Fenster K., Freeburg B., Hollard C., Wong C., RønhaveLaursen R., Ouwehand A.C.: The production and delivery of probiotics: A review of a practical approach. Microorganisms, 2019; 7: 83 FensterK. FreeburgB. HollardC. WongC. RønhaveLaursenR. OuwehandA.C. The production and delivery of probiotics: A review of a practical approach Microorganisms 2019 7 83 10.3390/microorganisms7030083646306930884906 Search in Google Scholar

[15] Floch M.H., Walker W.A., Guandalini S., Hibberd P., Gorbach S., Surawicz C., Sanders M.E., Garcia-Tsao G., Quigley E.M.M., Isolauri E., Fedorak R.N., Dieleman L.A.: Recommendations for probiotic use – 2008. J. Clin. Gastroenterol., 2008; 42, Suppl. 2: 104–108 FlochM.H. WalkerW.A. GuandaliniS. HibberdP. GorbachS. SurawiczC. SandersM.E. Garcia-TsaoG. QuigleyE.M.M. IsolauriE. FedorakR.N. DielemanL.A. Recommendations for probiotic use – 2008 J. Clin. Gastroenterol 2008 42 Suppl. 2 104 108 10.1097/MCG.0b013e31816b903f18542033 Search in Google Scholar

[16] Floch M.H., Walker W.A., Sanders M.E., Nieuwdorp M., Kim A.S., Brenner D.A., Qamar A.A., Miloh T.A., Guarino A., Guslandi M., Dieleman L.A., Ringel Y., Quigley E.M., Brandt L.J.: Recommendations for probiotic use – 2015 update: Proceedings and consensus opinion. J. Clin. Gastroenterol., 2015; 49, Suppl. 1: 69–73 FlochM.H. WalkerW.A. SandersM.E. NieuwdorpM. KimA.S. BrennerD.A. QamarA.A. MilohT.A. GuarinoA. GuslandiM. DielemanL.A. RingelY. QuigleyE.M. BrandtL.J. Recommendations for probiotic use – 2015 update: Proceedings and consensus opinion J. Clin. Gastroenterol 2015 49 Suppl. 1 69 73 10.1097/MCG.000000000000042026447969 Search in Google Scholar

[17] Francino M.P.: Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances. Front. Microbiol., 2016; 6: 1543 FrancinoM.P. Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances Front. Microbiol. 2016 6 1543 10.3389/fmicb.2015.01543470986126793178 Search in Google Scholar

[18] Fric P.: Probiotics and prebiotics – renaissance of a therapeutic principle. Open Med., 2007; 2: 237–270 FricP. Probiotics and prebiotics – renaissance of a therapeutic principle Open Med. 2007 2 237 270 10.2478/s11536-007-0031-5 Search in Google Scholar

[19] Gibson G.R., Rastall R.A., Roberfroid M.B.: Prebiotics. In: Colonic Microbiota, Nutrition and Health. ed.: G.R. Gibson, M.B. Roberfroid. Springer Netherlands, Dordrecht 1999, 101–124 GibsonG.R. RastallR.A. RoberfroidM.B. Prebiotics In: Colonic Microbiota, Nutrition and Health ed.: GibsonG.R. RoberfroidM.B. Springer Netherlands, Dordrecht 1999 101 124 10.1007/978-94-017-1079-4_7 Search in Google Scholar

[20] Główny Inspektorat Sanitarny – Gov.pl. https//www.gis.gov.pl/o-nas/aktualności/480-suplementy-kontrola-nik-i-uwagi-gis (20.01.2020) Główny Inspektorat Sanitarny Gov.pl. https//www.gis.gov.pl/o-nas/aktualności/480-suplementy-kontrola-nik-i-uwagi-gis (20.01.2020) Search in Google Scholar

[21] Gomes D.O., de Morais M.B.: Gut microbiota and the use of probiotics in constipation in children and adolescents: systematic review. Rev. Paul. Pediatr., 2019; 38: e2018123 GomesD.O. de MoraisM.B. Gut microbiota and the use of probiotics in constipation in children and adolescents: systematic review Rev. Paul. Pediatr. 2019 38 e2018123 10.1590/1984-0462/2020/38/2018123690925731778407 Search in Google Scholar

[22] Guarino A., Ashkenazi S., Gendrel D., Lo Vecchio A., Shamir R., Szajewska H., European Society for Pediatric Gastroenterology, Hepatology, and Nutrition, European Society for Pediatric Infectious Diseases: European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J. Pediatr. Gastroenterol. Nutr., 2014; 59: 132–152 GuarinoA. AshkenaziS. GendrelD. Lo VecchioA. ShamirR. SzajewskaH. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition, European Society for Pediatric Infectious Diseases European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014 J. Pediatr. Gastroenterol. Nutr. 2014 59 132 152 10.1097/MPG.000000000000037524739189 Search in Google Scholar

[23] Guidelines for the Evaluation of Probiotics in Food. Joint FAO/WHO Working Group Report on Draging Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada, April 30 and May 1, 2002 (20.11.2019) Guidelines for the Evaluation of Probiotics in Food Joint FAO/WHO Working Group Report on Draging Guidelines for the Evaluation of Probiotics in Food London, Ontario, Canada April 30 and May 1 2002 (20.11.2019) Search in Google Scholar

[24] Hamilton-Miller J.M., Shah S., Winkler J.T.: Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr., 1999; 2: 223–229 Hamilton-MillerJ.M. ShahS. WinklerJ.T. Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms Public Health Nutr. 1999 2 223 229 10.1017/S136898009900028210447251 Search in Google Scholar

[25] Hoa N.T., Baccigalupi L., Huxham A., Smertenko A., Van P.H., Ammendola S., Ricca E., Cutting A.S.: Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl. Environ. Microbiol., 2000; 66: 5241–5247 HoaN.T. BaccigalupiL. HuxhamA. SmertenkoA. VanP.H. AmmendolaS. RiccaE. CuttingA.S. Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders Appl. Environ. Microbiol. 2000 66 5241 5247 10.1128/AEM.66.12.5241-5247.20009245111097897 Search in Google Scholar

[26] Holmes E., Li J.V., Athanasiou T., Ashrafian H., Nicholson J.K.: Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol., 2011; 19: 349–359 HolmesE. LiJ.V. AthanasiouT. AshrafianH. NicholsonJ.K. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease Trends Microbiol. 2011 19 349 359 10.1016/j.tim.2011.05.006 Search in Google Scholar

[27] Holzapfel W.H., Haberer P., Snel J., Schillinger U., Huis in’t Veld J.H.: Overview of gut flora and probiotics. Int. J. Food Microbiol., 1998; 41: 85–101 HolzapfelW.H. HabererP. SnelJ. SchillingerU. Huis in’t VeldJ.H. Overview of gut flora and probiotics Int. J. Food Microbiol. 1998 41 85 101 10.1016/S0168-1605(98)00044-0 Search in Google Scholar

[28] Jach M., Łoś R., Maj M., Malm A.: Probiotyki – aspekty funkcjonalne i technologiczne. Post. Mikrobiol., 2013; 52: 161–170 JachM. ŁośR. MajM. MalmA. Probiotyki – aspekty funkcjonalne i technologiczne Post. Mikrobiol. 2013 52 161 170 Search in Google Scholar

[29] Jernberg C., Löfmark S., Edlund C., Jansson J.K.: Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J, 2007; 1: 56–66 JernbergC. LöfmarkS. EdlundC. JanssonJ.K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota ISME J 2007 1 56 66 10.1038/ismej.2007.318043614 Search in Google Scholar

[30] Kamińska E.: Skuteczność i bezpieczeństwo stosowania probiotyków na podstawie badań klinicznych przeprowadzonych u dzieci. Med. Wieku Rozwoj., 2012; 16: 240–251 KamińskaE. Skuteczność i bezpieczeństwo stosowania probiotyków na podstawie badań klinicznych przeprowadzonych u dzieci Med. Wieku Rozwoj. 2012 16 240 251 Search in Google Scholar

[31] Kaźmierska A.: Probiotyki – recepta na zdrowie? Kosmos, 2014; 63: 455–472 KaźmierskaA. Probiotyki – recepta na zdrowie? Kosmos 2014 63 455 472 Search in Google Scholar

[32] Kim H.J., Vazquez Roque M.I., Camilleri M., Stephens D., Burton D.D., Baxter K., Thomforde G., Zinsmeister A.R.: A randomized controlled trial of a probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol. Motil., 2005; 17: 687–696 KimH.J. Vazquez RoqueM.I. CamilleriM. StephensD. BurtonD.D. BaxterK. ThomfordeG. ZinsmeisterA.R. A randomized controlled trial of a probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloating Neurogastroenterol. Motil. 2005 17 687 696 10.1111/j.1365-2982.2005.00695.x16185307 Search in Google Scholar

[33] Kothari D., Patel S., Kim S.K.: Probiotic supplements might not be universally-effective and safe: A review. Biomed. Pharmacother., 2019; 111: 537–547 KothariD. PatelS. KimS.K. Probiotic supplements might not be universally-effective and safe: A review Biomed. Pharmacother. 2019 111 537 547 10.1016/j.biopha.2018.12.10430597307 Search in Google Scholar

[34] Krasnowska Y., Sikora T.: Suplementy diety a bezpieczeństwo konsumenta. Żywn. Nauka Technol. Jakość, 2011; 77: 5–23 KrasnowskaY. SikoraT. Suplementy diety a bezpieczeństwo konsumenta Żywn. Nauka Technol. Jakość 2011 77 5 23 Search in Google Scholar

[35] Kubiszewska I., Januszewska M., Rybka J., Gackowska L.: Bakterie kwasu mlekowego i zdrowie: czy probiotyki są bezpieczne dla człowieka? Postępy Hig. Med. Dośw., 2014; 68: 1325–1334 KubiszewskaI. JanuszewskaM. RybkaJ. GackowskaL. Bakterie kwasu mlekowego i zdrowie: czy probiotyki są bezpieczne dla człowieka? Postępy Hig. Med. Dośw. 2014 68 1325 1334 10.5604/17322693.112912025404621 Search in Google Scholar

[36] Kuśmierska A., Fol M.: Właściwości immunomodulacyjne i terapeutyczne drobnoustrojów probiotycznych. Probl. Hig. Epidemiol, 2014; 95: 529–540 KuśmierskaA. FolM. Właściwości immunomodulacyjne i terapeutyczne drobnoustrojów probiotycznych Probl. Hig. Epidemiol 2014 95 529 540 Search in Google Scholar

[37] La Fata G., Weber P., Mohajeri M.H.: Probiotics and the Gut Immune System: Indirect Regulation. Probiotics Antimicrob. Proteins, 2018; 10: 11–21 La FataG. WeberP. MohajeriM.H. Probiotics and the Gut Immune System: Indirect Regulation Probiotics Antimicrob. Proteins 2018 10 11 21 10.1007/s12602-017-9322-6580139728861741 Search in Google Scholar

[38] Lloyd-Price J., Abu-Ali G., Huttenhower C.: The healthy human microbiome. Genome Med, 2016; 8: 51 Lloyd-PriceJ. Abu-AliG. HuttenhowerC. The healthy human microbiome Genome Med 2016 8 51 10.1186/s13073-016-0307-y484887027122046 Search in Google Scholar

[39] Löfmark S., Jernberg C., Jansson J.K., Edlund C.: Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J. Antimicrob. Chemother., 2006; 58: 1160–1167 LöfmarkS. JernbergC. JanssonJ.K. EdlundC. Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes J. Antimicrob. Chemother. 2006 58 1160 1167 10.1093/jac/dkl42017046967 Search in Google Scholar

[40] López-Moreno A., Aguilera M.: Probiotics dietary supplementation for modulating endocrine and fertility microbiota dysbiosis. Nutrients, 2020; 12: 757 López-MorenoA. AguileraM. Probiotics dietary supplementation for modulating endocrine and fertility microbiota dysbiosis Nutrients 2020 12 757 10.3390/nu12030757714645132182980 Search in Google Scholar

[41] Lutyńska A., Augustynowicz E., Wiatrzyk A.: Problemy stosowania suplementów diety zawierających probiotyki. Probl. Hig. Epidemiol., 2012; 93: 493–498 LutyńskaA. AugustynowiczE. WiatrzykA. Problemy stosowania suplementów diety zawierających probiotyki Probl. Hig. Epidemiol. 2012 93 493 498 Search in Google Scholar

[42] Malla M.A., Dubey A., Kumar A., Yadav S., Hashem A., Abd Allah E.F.: Exploring the human microbiome: The potential future role of next–generation sequencing in disease diagnosis and treatment. Front. Immunol., 2019; 9: 2868 MallaM.A. DubeyA. KumarA. YadavS. HashemA. Abd AllahE.F. Exploring the human microbiome: The potential future role of next–generation sequencing in disease diagnosis and treatment Front. Immunol. 2019 9 2868 10.3389/fimmu.2018.02868633029630666248 Search in Google Scholar

[43] Manzanares W., Lemieux M., Langlois P.L., Wischmeyer P.E.: Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit. Care, 2016; 19: 262 ManzanaresW. LemieuxM. LangloisP.L. WischmeyerP.E. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis Crit. Care 2016 19 262 10.1186/s13054-016-1434-y499101027538711 Search in Google Scholar

[44] Marcinkiewicz J., Ciszek M., Bobek M., Strus M., Heczko P.B., Kurnyta M., Biedroń R., Chmielarczyk A.: Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int. J. Exp. Pathol., 2007; 88: 155–164 MarcinkiewiczJ. CiszekM. BobekM. StrusM. HeczkoP.B. KurnytaM. BiedrońR. ChmielarczykA. Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria Int. J. Exp. Pathol. 2007 88 155 164 10.1111/j.1365-2613.2007.00530.x251729917504445 Search in Google Scholar

[45] McDonald D., Ackermann G., Khailova L., Baird C., Heyland D., Kozar R., Lemieux M., Derenski K., King J., Vis-Kampen C., Knight R., Wischmeyer P.E.: Extreme dysbiosis of the microbiome in critical illness. mSphere, 2016; 1: e00199–00216 McDonaldD. AckermannG. KhailovaL. BairdC. HeylandD. KozarR. LemieuxM. DerenskiK. KingJ. Vis-KampenC. KnightR. WischmeyerP.E. Extreme dysbiosis of the microbiome in critical illness mSphere 2016 1 e00199 00216 10.1128/mSphere.00199-16500743127602409 Search in Google Scholar

[46] Miecznikow E.: O naturze ludzkiej. Zarys filozofii optymistycznej. Translated by F. Wermiński. Warszawa: Biblioteka Naukowa 1907 MiecznikowE. O naturze ludzkiej. Zarys filozofii optymistycznej Translated by WermińskiF. Warszawa Biblioteka Naukowa 1907 Search in Google Scholar

[47] Miele E., Pascarella F., Giannetti E., Quaglietta L., Baldassano R.N., Staiano A.: Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am. J. Gastroenterol., 2009; 104: 437–443 MieleE. PascarellaF. GiannettiE. QuagliettaL. BaldassanoR.N. StaianoA. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis Am. J. Gastroenterol. 2009 104 437 443 10.1038/ajg.2008.11819174792 Search in Google Scholar

[48] Mojka K.: Probiotyki, prebiotyki i synbiotyki – charakterystyka i funkcje. Probl. Hig. Epidemiol., 2014; 95: 541–549 MojkaK. Probiotyki, prebiotyki i synbiotyki – charakterystyka i funkcje Probl. Hig. Epidemiol. 2014 95 541 549 Search in Google Scholar

[49] Monteagudo-Mera A., Rastall R.A., Gibson G.R., Charalampopoulos D., Chatzifragkou A.: Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health. Appl. Microbiol. Biotechnol., 2019; 103: 6463–6472 Monteagudo-MeraA. RastallR.A. GibsonG.R. CharalampopoulosD. ChatzifragkouA. Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health Appl. Microbiol. Biotechnol. 2019 103 6463 6472 10.1007/s00253-019-09978-7666740631267231 Search in Google Scholar

[50] Mundula T., Ricci F., Barbetta B., Baccini M., Amedei A.: Effect of probiotics on oral candidiasis: A systematic review and meta-analysis. Nutrients, 2019; 11: 2449 MundulaT. RicciF. BarbettaB. BacciniM. AmedeiA. Effect of probiotics on oral candidiasis: A systematic review and meta-analysis Nutrients 2019 11 2449 10.3390/nu11102449683601031615039 Search in Google Scholar

[51] Najwyższa Izba Kontroli. https://www.nik.gov.pl/aktualnosci/nik-o-dopuszczaniu-do-obrotu-suplementow-diety.html (27.4.2020) Najwyższa Izba Kontroli https://www.nik.gov.pl/aktualnosci/nik-o-dopuszczaniu-do-obrotu-suplementow-diety.html (27.4.2020) Search in Google Scholar

[52] Natural Health Products Ingredients Database. https://www.webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_probiotics_english.pdf. (15.01.2020) Natural Health Products Ingredients Database https://www.webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_probiotics_english.pdf. (15.01.2020) Search in Google Scholar

[53] Nowak A., Śliżewska K., Libudzisz Z: Probiotyki – historia i mechanizmy działania. Żywn. Nauka Technol. Jakość, 2010; 4: 5–19 NowakA. ŚliżewskaK. LibudziszZ. Probiotyki – historia i mechanizmy działania Żywn. Nauka Technol. Jakość 2010 4 5 19 Search in Google Scholar

[54] Olszewska J., Jagusztyn-Krynicka E.K.: Human Microbiome Project – mikroflora jelit oraz jej wpływ na fizjologię i zdrowie człowieka. Post. Mikrobiol., 2012; 51: 243–256 OlszewskaJ. Jagusztyn-KrynickaE.K. Human Microbiome Project – mikroflora jelit oraz jej wpływ na fizjologię i zdrowie człowieka Post. Mikrobiol. 2012 51 243 256 Search in Google Scholar

[55] O’Toole P.W., Marchesi J.R., Hill C.: Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol., 2017; 2: 17057 O’TooleP.W. MarchesiJ.R. HillC. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics Nat. Microbiol. 2017 2 17057 10.1038/nmicrobiol.2017.5728440276 Search in Google Scholar

[56] Ouwehand A.C.: A review of dose-responses of probiotics in human studies. Benef. Microbes, 2017; 8: 143–151 OuwehandA.C. A review of dose-responses of probiotics in human studies Benef. Microbes 2017 8 143 151 10.3920/BM2016.014028008787 Search in Google Scholar

[57] Panasiuk A: Mikrobiota przewodu pokarmowego. Wydawnictwo Lekarskie PZWL, Warszawa 2019 PanasiukA Mikrobiota przewodu pokarmowego Wydawnictwo Lekarskie PZWL Warszawa 2019 Search in Google Scholar

[58] Pattani R., Palda V.A., Hwang S.W., Shah P.S.: Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: Systematic review and meta-analysis. Open Med., 2013; 7: 56–67 PattaniR. PaldaV.A. HwangS.W. ShahP.S. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: Systematic review and meta-analysis Open Med. 2013 7 56 67 Search in Google Scholar

[59] Renter G.: Present and future of probiotics in Germany and in Central Europe. Biosci. Microflora, 1997; 16: 43–51 RenterG. Present and future of probiotics in Germany and in Central Europe Biosci. Microflora 1997 16 43 51 10.12938/bifidus1996.16.43 Search in Google Scholar

[60] Rudzki L., Szulc A.: Wpływ jelitowej flory bakteryjnej na ośrodkowy układ nerwowy i jej potencjalne znaczenie w leczeniu zaburzeń psychicznych. Farmakoter. Psych. Neurol., 2013; 2: 69–77 RudzkiL. SzulcA. Wpływ jelitowej flory bakteryjnej na ośrodkowy układ nerwowy i jej potencjalne znaczenie w leczeniu zaburzeń psychicznych Farmakoter. Psych. Neurol. 2013 2 69 77 Search in Google Scholar

[61] Ruszkowski J., Szewczyk A., Witkowski J.M.: An overview of oral prebiotics, probiotics, synbiotics and post-biotic available on the Polish pharmacy market. Farm. Pol., 2018; 74: 114–122 RuszkowskiJ. SzewczykA. WitkowskiJ.M. An overview of oral prebiotics, probiotics, synbiotics and post-biotic available on the Polish pharmacy market Farm. Pol. 2018 74 114 122 10.32383/farmpol/119464 Search in Google Scholar

[62] Salminen S., von Wright A., Morelli L., Marteau P., Brassart D., de Vos W.M., Fondén R., Saxelin M., Collins K., Mogensen G., Birkeland S.E., Mattila-Sandholm T.: Demonstration of safety of probiotics – a review. Int. J. Food Microbiol., 1998; 44: 93–106 SalminenS. von WrightA. MorelliL. MarteauP. BrassartD. de VosW.M. FondénR. SaxelinM. CollinsK. MogensenG. BirkelandS.E. Mattila-SandholmT. Demonstration of safety of probiotics – a review Int. J. Food Microbiol. 1998 44 93 106 10.1016/S0168-1605(98)00128-7 Search in Google Scholar

[63] Saxelin M., Lassig A., Karjalainen H., Tynkkynen S., Surakka A., Vapaatalo H., Järvenpää S., Korpela R., Mutanen M., Hatakka K.: Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese. Int. J. Food Microbiol., 2010; 144: 293–300 SaxelinM. LassigA. KarjalainenH. TynkkynenS. SurakkaA. VapaataloH. JärvenpääS. KorpelaR. MutanenM. HatakkaK. Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese Int. J. Food Microbiol. 2010 144 293 300 10.1016/j.ijfoodmicro.2010.10.009 Search in Google Scholar

[64] Schrezenmeir J., de Vrese M.: Probiotics, prebiotics, and synbiotics – approaching a definition. Am. J. Clin. Nutr., 2001; 73: 361–364 SchrezenmeirJ. de VreseM. Probiotics, prebiotics, and synbiotics – approaching a definition Am. J. Clin. Nutr. 2001 73 361 364 10.1093/ajcn/73.2.361s Search in Google Scholar

[65] Suez J., Zmora N., Zilberman-Schapira G., Mor U., Dori-Bachash M., Bashiardes S., Zur M., Regev-Lehavi D., Ben-Zeev Brik R., Federici S., Horn M., Cohen Y., Moor A.E., Zeevi D., Korem T., et al.: Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell, 2018; 174: 1406–1423 SuezJ. ZmoraN. Zilberman-SchapiraG. MorU. Dori-BachashM. BashiardesS. ZurM. Regev-LehaviD. Ben-Zeev BrikR. FedericiS. HornM. CohenY. MoorA.E. ZeeviD. KoremT. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT Cell 2018 174 1406 1423 10.1016/j.cell.2018.08.047 Search in Google Scholar

[66] Summary of Product Characteristics (Charakterystyka Produktu Leczniczego) Enterol. https://www.pub.rejestrymedyczne.csioz.gov.pl/Pobieranie.ashx?type=7890-c (15.11.2019) Summary of Product Characteristics (Charakterystyka Produktu Leczniczego) Enterol https://www.pub.rejestrymedyczne.csioz.gov.pl/Pobieranie.ashx?type=7890-c (15.11.2019) Search in Google Scholar

[67] Szachta P., Pazgrat M., Cichy W., Muszyński Z., Ignyś I.: Szczepy probiotyczne –perspektywy i bezpieczeństwo. Gastroenterol. Pol., 2009; 16: 37–41 SzachtaP. PazgratM. CichyW. MuszyńskiZ. IgnyśI. Szczepy probiotyczne –perspektywy i bezpieczeństwo Gastroenterol. Pol. 2009 16 37 41 Search in Google Scholar

[68] Szajewska H.: Praktyczne zastosowanie probiotyków. Gastroenterol. Klin., 2014; 6: 16–23 SzajewskaH. Praktyczne zastosowanie probiotyków Gastroenterol. Klin. 2014 6 16 23 Search in Google Scholar

[69] Szajewska H.: Probiotyki w Polsce – kiedy, jakie i dlaczego? Gastroenterol. Klin., 2010; 2: 1–9 SzajewskaH. Probiotyki w Polsce – kiedy, jakie i dlaczego? Gastroenterol. Klin. 2010 2 1 9 Search in Google Scholar

[70] Szajewska H.: Probiotyki w gastroenterologii – aktualny stan wiedzy. Gastroenterol. Klin., 2015; 7: 20–26 SzajewskaH. Probiotyki w gastroenterologii – aktualny stan wiedzy Gastroenterol. Klin. 2015 7 20 26 Search in Google Scholar

[71] Szajewska H., Canani R.B., Guarino A., Hojsak I., Indrio F., Kolacek S., Orel R., Shamir R., Vandenplas Y., van Goudoever J.B., Weizman Z., ESPGHAN Working Group for ProbioticsPrebiotics: Probiotics for the prevention of antibiotic-associated diarrhea in children. J. Pediatr. Gastroenterol. Nutr., 2016; 62: 495–506 SzajewskaH. CananiR.B. GuarinoA. HojsakI. IndrioF. KolacekS. OrelR. ShamirR. VandenplasY. van GoudoeverJ.B. WeizmanZ. ESPGHAN Working Group for ProbioticsPrebiotics Probiotics for the prevention of antibiotic-associated diarrhea in children J. Pediatr. Gastroenterol. Nutr. 2016 62 495 506 10.1097/MPG.0000000000001081 Search in Google Scholar

[72] Szajewska H., Guarino A., Hojsak I., Indrio F., Kolacek S., Shamir R., Vandenplas Y., Weizman Z., European Society for Pediatric Gastroenterology, Hepatology, and Nutrition: Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J. Pediatr. Gastroenterol. Nutr., 2014; 58: 531–539 SzajewskaH. GuarinoA. HojsakI. IndrioF. KolacekS. ShamirR. VandenplasY. WeizmanZ. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics J. Pediatr. Gastroenterol. Nutr. 2014 58 531 539 10.1097/MPG.0000000000000320 Search in Google Scholar

[73] Szajewska H., Gyrczuk E., Horvath A.: Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J. Pediatr., 2013; 162: 257–262 SzajewskaH. GyrczukE. HorvathA. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial J. Pediatr. 2013 162 257 262 10.1016/j.jpeds.2012.08.004 Search in Google Scholar

[74] Szajewska H., Kołodziej M., Gieruszczak-Białek D., Skórka A., Ruszczyński M., Shamir R.: Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children – a 2019 update. Aliment. Pharmacol. Ther., 2019; 49: 1376–1384 SzajewskaH. KołodziejM. Gieruszczak-BiałekD. SkórkaA. RuszczyńskiM. ShamirR. Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children – a 2019 update Aliment. Pharmacol. Ther. 2019 49 1376 1384 10.1111/apt.15267 Search in Google Scholar

[75] Szymański H., Chmielarczyk A., Strus M., Pejcz J., Jawień M., Kochan P., Heczko P.B.: Colonisation of the gastrointestinal tract by probiotic L. rhamnosus strains in acute diarrhoea in children. Dig. Liver Dis., 2006; 38, Suppl. 2: 274–276 SzymańskiH. ChmielarczykA. StrusM. PejczJ. JawieńM. KochanP. HeczkoP.B. Colonisation of the gastrointestinal tract by probiotic L. rhamnosus strains in acute diarrhoea in children Dig. Liver Dis. 2006 38 Suppl. 2 274 276 10.1016/S1590-8658(07)60009-7 Search in Google Scholar

[76] The law on food safety and nutrition of 25 August 2006. Dz. U. 2006r. Nr 171, poz.1225; (09.12.2019) The law on food safety and nutrition of 25 August 2006 Dz. U. 2006r. Nr 171, poz.1225; (09.12.2019) Search in Google Scholar

[77] Tokarz-Deptuła B., Śliwa-Dominiak J., Adamiak M., Deptuła W.: Probiotyki a wybrane schorzenia u ludzi. Post. Mikrobiol., 2015; 54: 133–140 Tokarz-DeptułaB. Śliwa-DominiakJ. AdamiakM. DeptułaW. Probiotyki a wybrane schorzenia u ludzi Post. Mikrobiol. 2015 54 133 140 Search in Google Scholar

[78] Tompkins T.A., Mainville I., Arcand Y.: The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tract. Benef. Microbes, 2011; 2: 295–303 TompkinsT.A. MainvilleI. ArcandY. The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tract Benef. Microbes 2011 2 295 303 10.3920/BM2011.002222146689 Search in Google Scholar

[79] Tsai Y.L., Lin T.L., Chang C.J., Wu T.R., Lai W.F., Lu C.C., Lai H.C.: Probiotics, prebiotics and amelioration of diseases. J. Biomed. Sci., 2019; 26: 3 TsaiY.L. LinT.L. ChangC.J. WuT.R. LaiW.F. LuC.C. LaiH.C. Probiotics, prebiotics and amelioration of diseases J. Biomed. Sci. 2019 26 3 10.1186/s12929-018-0493-6632057230609922 Search in Google Scholar

[80] Wasilewska E., Złotkowska D., Pijagin M.E.: The role of intestinal microflora and probiotic bacteria in prophylactic and development of colorectal cancer. Postępy Hig. Med. Dośw., 2013; 67: 837–847 WasilewskaE. ZłotkowskaD. PijaginM.E. The role of intestinal microflora and probiotic bacteria in prophylactic and development of colorectal cancer Postępy Hig. Med. Dośw. 2013 67 837 847 10.5604/17322693.106184724018449 Search in Google Scholar

[81] Whorwell P.J., Altringer L., Morel J., Bond Y., Charbonneau D., O’Mahony L., Kiely B., Shanahan F., Quigley E.M.: Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am. J. Gastroenterol., 2006; 101: 1581–1590 WhorwellP.J. AltringerL. MorelJ. BondY. CharbonneauD. O’MahonyL. KielyB. ShanahanF. QuigleyE.M. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome Am. J. Gastroenterol. 2006 101 1581 1590 10.1111/j.1572-0241.2006.00734.x16863564 Search in Google Scholar

[82] World Gastroenterology Organisation Global Guidelines. Probiotics and prebiotics. https://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english (27.4.2020) World Gastroenterology Organisation Global Guidelines Probiotics and prebiotics https://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english (27.4.2020) Search in Google Scholar

[83] Yan F., Polk D.B.: Probiotics and immune health. Curr. Opin. Gastroenterol., 2011; 27: 496–501 YanF. PolkD.B. Probiotics and immune health Curr. Opin. Gastroenterol. 2011 27 496 501 10.1097/MOG.0b013e32834baa4d400699321897224 Search in Google Scholar

[84] Yoon M.Y., Yoon S.S.: Disruption of the gut ecosystem by antibiotics. Yonsei Med. J., 2018; 59: 4–12 YoonM.Y. YoonS.S. Disruption of the gut ecosystem by antibiotics Yonsei Med. J. 2018 59 4 12 10.3349/ymj.2018.59.1.4572536229214770 Search in Google Scholar